Keytruda 100 MG/4 ML vial 4ML

Ended Awarded

Contract number
SPE2DR26FQQZ9
Awardee
Awarding agency
Obligated
$174,912

Award facts

Contract value 100% obligated
$174,911.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $174,911.80 delivery order to DMS Pharmaceutical Group Inc. on June 2, 2026, for Keytruda 100 mg/4 mL vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

The order is issued under DMS Pharmaceutical's single-award indefinite delivery contract (SPE2DX) with the Defense Logistics Agency, which carries a $499.999 billion ceiling and runs through December 31, 2036. Place of performance is Park Ridge, Illinois. The order is priced on a firm fixed-price basis with an ultimate completion date of June 24, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business.

Quick answers

Who was awarded contract SPE2DR26FQQZ9?

SPE2DR26FQQZ9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2026.

How much is contract SPE2DR26FQQZ9 worth?

The government has obligated $174,912 on SPE2DR26FQQZ9.

Is contract SPE2DR26FQQZ9 an order under another contract?

Yes. SPE2DR26FQQZ9 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.

Was contract SPE2DR26FQQZ9 competed?

The extent of competition for SPE2DR26FQQZ9 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award